Trevi Therapeutics (TRVI) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.13
-0.11
-0.08
-0.06

Details

Expected EPS
-0.08
Actual EPS
-0.07
Surprise EPS
0.01
Surprise Percent
+12.5%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.07 per share for Q2 2023.

0 Comments

Share your thoughts